Les personnes handicapées sont confrontées à des besoins spécifiques auxquels la communauté n’accorde pas toute l’attention requise. Un nombre important de cette couche vulnérable vit dans des conditions déplorables, à la limite déshumanisantes.
La présente évaluation vise à fournir une meilleure compréhension des capacités et des besoins du Collège National des Gynécologues Obstétriciens du Bénin (CNGOB). De façon spécifique, il vise l’identification des principaux besoins en matière de plaidoyer pour l'avortement sécurisé ...dans le cadre d’un futur projet multi-pays. En outre, elle a essayé d’apporter plus de clarté sur la façon dont la FIGO peut plus efficacement renforcer les capacités des sociétés nationales, dont le CNGOB. Pour ce fait, elle s’est basée sur la revue documentaire, une enquête en ligne adressée aux acteurs clés du collège, des entretiens avec différentes parties prenantes puis sur un atelier des acteurs membres et partenaire du CNGOB.
more
Reading Material for ASHA no.8
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
El informe Indicadores básicos 2019: tendencias de la salud en las Américas comienza con un panorama demográfico de la Región que muestra los cambios que han ocurrido a lo largo de los últimos 25 años. Estos indicadores demográficos proporcionan un contexto útil para comprender mejor las car...acterísticas de la población y el efecto que tienen en la salud. Los gráficos están acompañados de breves descripciones en las que se destaca la información más importante.
more
Un análisis desde la perspectiva del sector de la salud en América Latina y el Caribe
Washington, D.C., 2017
This handbook aims to give practical guidance to support development organisations to mainstream disability into their work. It is primarily intended for VSO programmes, but could be useful to other development actors interested in mainstreaming disability, such as NGOs, gover...nment and donors
more
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...of Essential Medicines (Model List). WHO is committed to supporting Member States in sharing best practices in selecting
essential medicines, and in developing processes for the selection of medicines for national essential medicines lists (national EMLs, or NEMLs) consistent with the evidence-based methods used for updating the WHO Model List.
more
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...Module 4: Treatment - Drug-Resistant Tuberculosis Treatment provides practical guidance on how to put in place the recommendations at the scale needed to achieve national and global impact.
The document provides information on different aspects of care and support for TB patients. In particular, the handbook provides practical guidance on the implementation of the interventions that enable treatment adherence such as social support, treatment administration options, digital adherence technologies. The practical guidance also includes models of care for all TB patients, models of care for children and adolescents, integrated care for TB, HIV and comorbidities, engagement of private sector, managing of TB in health emergencies. This new practical handbook also includes two important chapters on health education and counselling, and palliative care for patients with TB.
more
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
more
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with... Leishmania infection are highly infectious to sandflies, and an increase in the coinfection rate in an endemic area is likely to increase the effective infective reservoir.
more
Le présent Atlas 2022 a été préparé par une équipe centrale du groupe organique Sous-Directrice régionale du Bureau régional de l’OMS pour l’Afrique sous la direction et l’orientation de Lindiwe Makubalo, directrice du groupe organique, et de Humphrey Cyprian Karamagi, chef de ...l’équipe Analyse des données et gestion du savoir. L’équipe technique principale était composée de Berence Relisy Ouaya Bouesso, Anaclet Geraud Nganga Koubemba, Bertha Kembabazi, Jadice Mandimba, Aminata Seydi, Sokona Sy, Monde Mambimongo Wangou et Auge Wilson, qui ont travaillé sous la coordination de Serge Bataliack.
more